MUC1 and COVID-19: Elevated levels of inflammatory markers, such as LDH, KL-6, ferritin, D-dimer, CRP, and IL-6, as well as decreased lymphocyte counts, have been reported to be associated with poor outcomes in patients with COVID-19 [17,18].